LATEST
Maximus Federal Services agreed to acquire Agile DefensenewMount Logan Management agreed to acquire Alternative Fund AdvisorsnewDime Commercial Bancshares / ES BancsharesnewSalesforce agreed to acquire BrazeJV Investors / Oro Mobility HoldingsSilgan / Trivium: minority stakeBF International Best Fields Best Food / DiagramOpenWorld agreed to acquire Blocksight HoldingsMerck KGaA agreed to acquire Silence TherapeuticsLarry A. Powalisz / Adia LabsTTM Technologies / Ophir® Optics businessTradeweb Markets agreed to acquire Trumid Holdings
Open App
Agreement signedPublished 6 Feb 2024

Veracyte /
C2i Genomics

Veracyte agrees to buy C2i Genomics

Buy side: Veracyte
Buy sideVeracyte
Target: C2i Genomics
TargetC2i Genomics
Source · 6 Feb 2024Source-verified
See the source
Buy side: Veracyte
Buy sideVeracyte
Target: C2i Genomics
TargetC2i Genomics
01 / BuyerVeracyte
02 / TargetC2i Genomics
Source-verified
01

What happened

Veracyte agreed to acquire C2i Genomics, according to a filing dated Feb. 6, 2024.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

Veracyte agrees to buy C2i Genomics

This document is the source for the companies, stage and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Announced

    The source this page is built from.

    Source-verified

  2. Published by the source

    The source this page is built from.

    Source-verified

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request an inviteAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.